In summary, we have demonstrated that BME induces autophagic cell death in breast cancer cells, both in vitro and in vivo, through the LC3B/AMPK/mTOR signaling pathways (Figure 8). This evidence concerns the gene MAP1LC3B and breast carcinoma.